Editions:  Austria · Denmark · France · Germany · Italy · Norway · Spain · Sweden · Switzerland
Advertisement

AstraZeneca settles Crestor lawsuit

Share this article

AstraZeneca settles Crestor lawsuit
14:58 CET+01:00
Anglo-Swedish pharmaceutical company AstraZeneca on Monday said it had settled a long-running patent lawsuit over its top-selling drug Crestor.

AstraZeneca said in a statement that the deal would protect its sales of the anti-cholesterol drug until 2016.

"AstraZeneca today announced that it has entered into a settlement agreement in its US patent infringement litigation against Watson Laboratories, Inc., Actavis, Inc. (formerly known as Watson Pharmaceuticals, Inc.), and EGIS Pharmaceuticals," the company said.

Crestor generated $6.25 billion of sales in 2012, down from $6.6 billion in 2011 after losing patent protection in certain regions.

AstraZeneca's announcement comes after it last week said it was cutting 3,900 jobs - in a major restructuring of the group over the next three years.

The group currently employs about 57,000 staff worldwide.

AFP/The Local/og

Follow The Local on Twitter

Get notified about breaking news on The Local

Share this article

Advertisement

From our sponsors

'Lagom' leadership: the secret to Swedish success?

Is the Swedish approach to leadership really as special as people think? The Local asks a non-Swedish manager at telecom giant Ericsson for a frank appraisal of Swedes' so-called 'lagom' leadership style.

Advertisement
Advertisement
Jobs
Click here to start your job search
Advertisement
Advertisement

Popular articles

Advertisement
Advertisement